ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease
Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint
MDV3100 Improves Survival, Reduces Death Risk by 37%
Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication
Elevated Baseline Glucose Levels Associated With Higher Cancer Risk
Oncotype DX Cancer Test Can Predict Recurrence
Signet Cell A Rising Trend In Patients Under Age 40
FIT More Effective Than gFOBT In All Colonoscopy Capacities
Tumor Treating Fields Therapy Increased Three-Year Survival
Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy
New Algorithm Completes Scan Three Times Faster Than Before
Survivorship Studies Unfocused As Total Research Increases
Trials Approved by NCI CTEP Last Month
Agency Approves HPV Test That Detects 14 High-Risk Strains
Alimta Granted Approval As NSCLC Continuation Therapy
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - In the epicenter of the measles outbreak, “love thy neighbor” does not extend to vaccination rates
A dispatch from Lancaster County - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Anthony El-Khoueiry named director of USC Norris
- As Iowa goes blue, incoming Gov. Rob Sand and Sen. Josh Turek offer plans to address the state’s “cancer crisis”
- Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on
